Sign in
Long-term Anti-VEGF Treatment Following Vitrectomy for Endophthalmitis in Patients With Neovascular AMD
Zofia Anna Nawrocka (vel Michalewska), MD, PhD
Annual Meeting Talks
2018
Outcomes in Proliferative Diabetic Retinopathy Patients Lost to Follow-up After Panretinal Photocoagulation Versus Antivascular
Daniel Su, MD
Updates from the Field
Phase IIIb TALON study of brolucizumab versus aflibercept in a matched treat-and-extend regimen to treat neovascular AMD: 32-week primary outcomes
Carl D. Regillo, MD
2022
Category: AMD-Neovascular